Cystic Fibrosis: Catching It Early
When screening for cystic fibrosis (CF) in newborns, time is of the essence. And a new screening test could cut the current wait time for results in half.
New Cystic Fibrosis Rx Shows Promise
Today an advisory committee of the U.S. Food and Drug Administration (FDA) voted 12 to 1 to recommend that the FDA approve the potential ivacaftor/lumacaftor combination drug (Orkambi).
Cirrhosis Survival Spiked
Good news for cirrhosis patients: Survival may be much more common than it once was.
FDA Approves TOBI Podhaler
The US Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
Favorable Pregnancies With Cystic Fibrosis
Although women with cystic fibrosis typically have lung problems, they can give birth to healthy children without causing significant damage to their lungs.
Are You Angry – or Grateful?
Seeking strength from God to deal with illness is just as common as being angry at God for an illness. But the way these two attitudes affect an individual is quite different.
A Cystic Fibrosis Therapy not for Kids
Studies show that concentrated saline therapy provides some benefit to adults and older children with cystic fibrosis.
Harmless Bacteria Becomes Fatal in CF
Something harmless could turn deadly under the right circumstances. Researchers are beginning to understand how a harmless bacteria becomes a fatal infection in cystic fibrosis patients.
Cystic Fibrosis Goes 3-D
Movies are not the only thing getting the 3-D treatment. Researchers are using 3-D models of cystic fibrosis to discover new targets for treatment.
New Tool in the Fight Against Cystic Fibrosis
Tissue is the issue when it comes to developing new drugs. Scientists have begun to develop tissue in the lab for testing new cystic fibrosis treatments.